Skip to main content
Log in

DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc

  • Original Paper
  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

Substantial evidence suggests that non-coding RNA plays a vital role in human cancer, especially long non-coding RNA (lncRNA) with a length greater than 200nt. Herein, we found a lncRNA facilitating human colorectal cancer (CRC) progression. DLGAP1-AS2 was significantly increased in CRC tissues and cell lines. Knockdown of DLGAP1-AS2 inhibited CRC cell proliferation, migration, invasion in vitro, and tumor growth in vivo. The subcellular localization of DLGAP1-AS2 was translocated from the cytoplasm of normal cells to the nucleus of CRC cells due to reduced levels of N6-methyladenosine (m6A) modification. Further, through the screening of a series of signal pathways, we found that Myc pathway was involved in the effect of DLGAP1-AS2. Silencing of DLGAP1-AS2 markedly reduced Myc mRNA and protein levels. Blockade of Myc effectively abolished the enhanced aggressive behaviors of CRC cells caused by DLGAP1-AS2 overexpression. Mechanistically, DLGAP1-AS2 directly bound CTCF, a well-known transcriptional repressor of Myc, resulting in reduced binding of CTCF on Myc promoter and activating Myc transcription. The second hairpin structure of DLGAP1-AS2 was critical for the interaction between DLGAP1-AS2 and CTCF in the nucleus. Taken together, our study reveals the oncogenic regulatory axis of DLGAP1-AS2/CTCF/Myc in CRC, implying a promising targeted therapy for clinical application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The data in this study are available from the corresponding author upon request.

References

  • Ali T, Grote P (2020) Beyond the RNA-dependent function of LncRNA genes. Elife. https://doi.org/10.7554/eLife.60583

    Article  PubMed  PubMed Central  Google Scholar 

  • Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96(4):1297–1325

    Article  CAS  PubMed  Google Scholar 

  • Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J Cell Biol 220:2

    Article  Google Scholar 

  • Chen K, Zhang Z, Yu A, Li J, Liu J, Zhang X (2020) lncRNA DLGAP1-AS2 knockdown inhibits hepatocellular carcinoma cell migration and invasion by regulating miR-154–5p methylation. Biomed Res Int 2020:6575724

    PubMed  PubMed Central  Google Scholar 

  • Dai D, Wang H, Zhu L, Jin H, Wang X (2018) N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis 9(2):124

    Article  PubMed  PubMed Central  Google Scholar 

  • Dekker E, Tanis PJ, Vleugels J, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394(10207):1467–1480

    Article  PubMed  Google Scholar 

  • Ferre F, Colantoni A, Helmer-Citterich M (2016) Revealing protein-lncRNA interaction. Brief Bioinform 17(1):106–116

    Article  CAS  PubMed  Google Scholar 

  • Ghanam AR, Bryant WB, Miano JM (2022) Of mice and human-specific long noncoding RNAs. Mamm Genome 33(2):281–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He L, Li H, Wu A, Peng Y, Shu G, Yin G (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18(1):176

    Article  PubMed  PubMed Central  Google Scholar 

  • Hu BB, Wang XY, Gu XY, Zou C, Gao ZJ, Zhang H, Fan Y (2019) N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer 18(1):178

    Article  PubMed  PubMed Central  Google Scholar 

  • Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L (2020) IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ 27(6):1782–1794

    Article  CAS  PubMed  Google Scholar 

  • Li B, Zhang G, Wang Z, Yang Y, Wang C, Fang D, Liu K, Wang F, Mei Y (2021) c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA. Cell Death Dis 12(11):1006

    Article  PubMed  PubMed Central  Google Scholar 

  • Llombart V, Mansour MR (2021) Therapeutic targeting of “undruggable” MYC. EBioMedicine 75:103756

    Article  PubMed  PubMed Central  Google Scholar 

  • Lu J, Xu Y, Xie W, Tang Y, Zhang H, Wang B, Mao J, Rui T, Jiang P, Zhang W (2021) Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer. Cell Death Discov 7(1):255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z (2019) The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol 12(1):121

    Article  PubMed  PubMed Central  Google Scholar 

  • Meyer KD, Jaffrey SR (2014) The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol 15(5):313–326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miao W, Li N, Gu B, Yi G, Su Z, Cheng H (2020) LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression. J Biochem 167(4):411–418

    Article  CAS  PubMed  Google Scholar 

  • Peng WX, Koirala P, Mo YY (2017) LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36(41):5661–5667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Qi Y, Shan Y, Li S, Huang Y, Guo Y, Huang T, Zhao X, Jia L (2021) LncRNA LEF1-AS1/LEF1/FUT8 Axis mediates colorectal cancer progression by regulating alpha1, 6-Fucosylationvia Wnt/beta-catenin pathway. Dig Dis Sci. https://doi.org/10.1007/s10620-021-07051-w

    Article  PubMed  Google Scholar 

  • Ren C, Zhang Z, Wang S, Zhu W, Zheng P, Wang W (2020) Circular RNA hsa_circ_0001178 facilitates the invasion and metastasis of colorectal cancer through upregulating ZEB1 via sponging multiple miRNAs. Biol Chem 401(4):487–496

    Article  CAS  PubMed  Google Scholar 

  • Ross CJ, Ulitsky I (2022) Discovering functional motifs in long noncoding RNAs. Wiley Interdiscip Rev RNA. https://doi.org/10.1002/wrna.1708

    Article  PubMed  Google Scholar 

  • Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, He E, Shen B, He C (2017) YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. https://doi.org/10.7554/eLife.3131

    Article  PubMed  PubMed Central  Google Scholar 

  • Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5(10):1024–1039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, Li G, Wang G, Song J, Li Z, Zhang Z, Yuan W, Li X (2019) YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene 38(14):2627–2644

    Article  CAS  PubMed  Google Scholar 

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71(3):209–249

    Article  PubMed  Google Scholar 

  • Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (lond) 41(2):109–120

    Article  Google Scholar 

  • Wancata LM, Banerjee M, Muenz DG, Haymart MR, Wong SL (2016) Conditional survival in advanced colorectal cancer and surgery. J Surg Res 201(1):196–201

    Article  PubMed  Google Scholar 

  • Wang L, Tang L, Ge T, Zhu F, Liu D, Guo H, Qian P, Xu N (2021) LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer. Bmc Pulm Med 21(1):277

    Article  PubMed  PubMed Central  Google Scholar 

  • Widagdo J, Anggono V, Wong JJ (2021) The multifaceted effects of YTHDC1-mediated nuclear m(6)A recognition. Trends Genet. https://doi.org/10.1016/j.tig.2021.11.005

    Article  PubMed  Google Scholar 

  • Xu L, Huan L, Guo T, Wu Y, Liu Y, Wang Q, Huang S, Xu Y, Liang L, He X (2020) LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1alpha. Oncogene 39(46):7005–7018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang C, Hu Y, Zhou B, Bao Y, Li Z, Gong C, Yang H, Wang S, Xiao Y (2020) The role of m(6)A modification in physiology and disease. Cell Death Dis 11(11):960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yuan J, Song Y, Pan W, Li Y, Xu Y, Xie M, Shen Y, Zhang N, Liu J, Hua H, Wang B, An C, Yang M (2020) LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5. Oncogene 39(43):6664–6676

    Article  CAS  PubMed  Google Scholar 

  • Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20(10):608–624

    Article  CAS  PubMed  Google Scholar 

  • Zhong L, Ming Z, Xie G, Fan C, Piao X (2020) Recent advances on the semi-supervised learning for long non-coding RNA-protein interactions prediction: a review. Protein Pept Lett 27(5):385–391

    Article  CAS  PubMed  Google Scholar 

  • Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, Zeng H, Qin Y, Wan X, Qiao Y, Qiu Y, Teng Y, Liu M (2021) A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene 40(9):1609–1627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

CFR: designed this study and wrote the draft; HBH, JJP, and QC: performed all experiments and collected data; CFR, WHW, XBG, and JB: provided technical assistance and guidance. All authors approved the final version.

Corresponding author

Correspondence to Chunfeng Ren.

Ethics declarations

Conflict of interest

The authors declare that they have no financial conflicts of interest.

Ethical approval

This study was approved by the Medical Ethics Committee and Institutional Animal Care and Use Committee (IACUC) of the First Affiliated Hospital of Zhengzhou University.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 86 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, C., Han, H., Pan, J. et al. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc. Mamm Genome 33, 672–683 (2022). https://doi.org/10.1007/s00335-022-09963-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-022-09963-y

Navigation